New data involves nonviral, targeted payload delivery to the liver using ultrasound mediated delivery (UMD), resulting in up ...

Preclinical data findings illustrate power of Cellarity’s discovery platform, which leverages transcriptomics and AI to discover previously unseen biological pathways to create novel cell ...

CSHL postdoc Iacopo Gentile has devised a new system for identifying redundant genes and predicting how certain genetic ...

As global temperatures rise, Cold Spring Harbor Laboratory (CSHL) scientists work to grow stronger, more resilient crops. Yet ...

Uncomfortable woman steals the show at Trump's Kennedy Center event, leaving fans buzzing. What really happened? #Trump ...

Epicrispr Biotechnologies, a clinical-stage company pioneering gene-modulating therapies, today announced that Amber Salzman, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P.

A disease that has stalked humanity for millennia may have finally met its match. Mycobacterium tuberculosis, the pathogen ...

New research shows FAM72 family overexpression predicts poorer liver cancer outcomes and introduces a two-gene FAM72 risk ...

(51 of 54) remained free from the burden of continuous prophylaxis treatment through five years following a single infusion of HEMGENIX, demonstrating sustained therapeutic benefit- At year five, mean ...

A new study suggests treatment-resistant depression may be rooted in the immune system. Trauma, stress biology, and ...

Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off ...

In recent years, the complex ecosystem surrounding cancer cells, known as the tumor microenvironment (TME), has become a ...